Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fortress Biotech Inc (NQ: FBIO )

0.8000 -0.0399 (-4.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 355,950
Open 0.8278
Bid (Size) 0.8010 (5)
Ask (Size) 0.8199 (1)
Prev. Close 0.8399
Today's Range 0.8000 - 0.8619
52wk Range 0.7710 - 3.810
Shares Outstanding 106,321,875
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public... 
From MicroCap Rodeo
Via AccessWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga

Performance

YTD
-70.91%
-70.91%
1 Month
-12.64%
-12.64%
3 Month
-44.44%
-44.44%
6 Month
-70.91%
-70.91%
1 Year
-76.81%
-76.81%

More News

Read More
Looking Into Fortress Biotech's Return On Capital Employed
Via Benzinga
Recap: Fortress Biotech Q4 Earnings
Via Benzinga
Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Benzinga Announces This Week's All Access Guests
Via Benzinga
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
From MicroCap Rodeo
Via AccessWire
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI)
From Aegis Capital Corp.
Via AccessWire
Topics Retirement
Exposures Pension
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
Via Benzinga
Exposures COVID-19
Fortress-Backed Cyprium's Formulated Copper Histidinate Shows Efficacy In Rare Pediatric Disease
Via Benzinga
33 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Exposures Product Safety
52 Biggest Movers From Yesterday
Via Benzinga
AstraZeneca Buys Fortress-Biotech Founded Caelum For $500M
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.